摘要
多发性骨髓瘤（MM）是一种起源于B细胞系并能够产生单克隆免疫球蛋白的恶性增生性疾病。我国骨髓瘤发病率为1/10万,约占恶性肿瘤的1%,发病年龄大都在50-60岁之间。MM尚无根治的方法。现对MM的联合治疗、干细胞移植、新型药物治疗及并发症的治疗进行论述。
Multiple myeloma（MM） is a kind of malignant hyperplastic diseases,which is origined from B cell line and can produce monoclonal immunoglobulin. The incidence of MM is a 100000th in China, which occupies one percent of malignant tumors. The morbidity age is mainly from 50 to 60 years old. The radical cure of MM is not found. The combined treatment of MM, stem cell transplatation, new type of pharmocotherapy and the treatment of complications are discussed.
出处
《现代诊断与治疗》
CAS
2007年第5期291-294,共4页
Modern Diagnosis and Treatment
关键词
多发性骨髓瘤
联合治疗
干细胞移植
新型药物治疗
并发症
Multiple myeloma
Combined treatment
Stem cell transplatation
New type of pharmocotherapy
Complication
